Company: SXTPW
Filing Date: 2025-08-15
Form Type: PRE 14A
Source: 0001213900-25-077435
Chunk: 25

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-15
Form: PRE 14A
Chunk 25
---
 sessions are attended only by the non-management directors.
Our independent directors meet in executive sessions at least once per year and met once in 2024.

. Information and data
important to the directors’ understanding of the business or matters to be considered at a Board or Board committee meeting are,
to the extent practical, distributed to the directors sufficiently in advance of the meeting to allow careful review prior to the meeting.

. The Board has access to management
and outside advisers as follows:

| ● | Access to Management                                                                                                                    
 and Employees. Directors have full and unrestricted access to the management and employees of the Company. Additionally, key            
 members of management attend Board meetings to present information about the results, plans and operations of the business within their 
 areas of responsibility.                                                                                                                |

| ● | Access to Outside Advisors.                                                                                                            
 The Board and its committees may retain counsel or consultants without obtaining the approval of any officer of the Company in advance 
 or otherwise. The Audit Committee has the sole authority to retain and terminate the independent auditor. The Nominating and Corporate 
 Governance Committee has the sole authority to retain search firms to be used to identify director candidates.                         |

.
The Board maintains overall responsibility for overseeing the Company’s risk management, including succession planning, product
safety and information and digital security. In furtherance of its responsibility, the Board has delegated specific risk-related responsibilities
to the Audit Committee.

The Audit Committee engages in substantive discussions
of risk management at its regular committee meetings held during the year. At these meetings, it receives functional risk review reports
covering significant areas of risk from the employees responsible for these functional areas, as well as receiving reports from the Chief
Financial Officer who reports directly to the Chairperson of the Audit Committee. The Audit Committee also receives reports at each meeting
regarding legal and regulatory risks from management and meets in separate executive sessions with our independent auditors and our Chief
Financial Officer. The Audit Committee provides a summary to the full Board at certain Board meetings of the risk area reviewed together
with any other risk related subjects discussed at the Audit Committee meeting.

.
Information security and privacy has been and remains of the utmost importance to the Company in light of the value we place on maintaining
the trust and confidence of our customers, employees and other stakeholders. Accordingly, our Chief Executive Officer and President advises
the Audit Committee and the full Board at least once per year on our program for managing information security risks, including data privacy
and data protection risks.

. Stockholders
and other parties interested in communicating directly